PSHG
Performance Shipping Inc.
There isn't enough reported data to score PSHG yet.
VRT
Vertiv Holdings Co
VRT's fundamentals are strong and it looks cheap: trading at 39x earnings, about half its usual 72x. Analysts expect strong earnings growth.
PSHG Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Stable | |
| Unavailable | |
| Strong |
PSHG's balance sheet is currently strong, and its profitability is stable. There isn't enough data to rate its revenue and cash flow.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
PSHG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 1.1x | $0.96 | -52% |
| Fair | 1.2x | $1.12 | -45% |
| Expensive | 1.4x | $1.30 | -36% |
| Current | 2.2x | $2.02 | — |
| Forward | 3.3x | $2.02 | — |
Historical ranges are pointers, not guarantees.
PSHG's PE is 2.2x, but its earnings don't support one, so it isn't a reliable read right now.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT has the edge over PSHG in the historical PE scenario, which offers more potential upside but is not a forecast.
PSHG Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Stable | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect PSHG's earnings and profitability to decline, with its revenue holding steady. However, they disagree widely on these estimates.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
VRT has the edge over PSHG on the outlook, with more favorable valuation and earnings expectations.
PSHG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.61 | -33% |
| Q2 2026 | $0.91 | -42% |
| Q4 2025 | $1.28 | +15% |
| Q2 2025 | $1.56 | +6.8% |
| Q4 2024 | $1.11 | -42% |
| Q2 2024 | $1.46 | -75% |
| Q4 2023 | $1.91 | +$24.37 |
| Q4 2022 | -$22.46 | +$6.49 |
| Q4 2021 | -$28.95 | -284% |
PSHG's earnings per share have fallen from their peak: $0.91 over the past year, against $15.75 in late 2020.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over PSHG in the latest year-over-year earnings comparison.
PSHG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $68.4M | +73% |
| Q4 2025 | $44.7M | +0.3% |
| Q2 2025 | $39.5M | -7.9% |
| Q4 2024 | $44.6M | -7.1% |
| Q2 2024 | $42.9M | -30% |
| Q4 2023 | $48M | -3.9% |
| Q2 2023 | $61M | +141% |
| Q4 2022 | $49.9M | +37% |
PSHG's revenue has held roughly level: $68M last quarter, up 60% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 47% | -2 points |
| Q4 2025 | 34% | -46 points |
| Q2 2025 | 93% | +32 points |
| Q4 2024 | 47% | -28 points |
| Q2 2024 | 49% | +38 points |
| Q4 2023 | 80% | +103 points |
| Q2 2023 | 61% | +90 points |
| Q4 2022 | 74% | +64 points |
PSHG has the edge over VRT on profitability, with a higher operating margin.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over PSHG in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT's operating margin was 23% last quarter, up 3.5 points from the same quarter a year ago, near the top of its range since 2020.
PSHG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | $28M | +3% |
| Q2 2024 | $31.7M | -21% |
| Q4 2023 | $27.1M | -21% |
| Q2 2023 | $40.3M | +$44.7M |
| Q4 2022 | $34.5M | +$39.4M |
| Q2 2022 | -$4.4M | -$2.8M |
| Q4 2021 | -$4.9M | -137% |
| Q4 2020 | $13.2M | +$67.5M |
PSHG has burned cash in most quarters: $93M over the past year, up 42% from the year before.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT generated $3.1B in free cash flow over the past year, up 127% from the year before.
PSHG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +171K shares |
| 1 year | -0.3% | -119K shares |
PSHG has the edge over VRT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q2 2024 | — |
| Q4 2023 | $1.3M |
| Q2 2023 | $1.4M |
| Q4 2021 | — |
| Q2 2021 | — |
| Q4 2020 | $656,000 |
VRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -64.9K shares |
| 1 year | +0.4% | +1.8M shares |
| 3 years | +1.1% | +4.4M shares |
| 5 years | +10% | +36M shares |
| Available history | +63% | +152M shares |
VRT has 393M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $599.9M |
PSHG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
| Q2 2024 | -0.1x | Net Cash |
| Q4 2023 | -0.1x | Net Cash |
| Q2 2023 | 0.6x | Very low |
| Q4 2022 | 1.8x | Healthy |
| Q4 2020 | 3.6x | Elevated |
| Q4 2015 | 42.5x | High |
PSHG has more cash than debt.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has more cash than debt.
PSHG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.1 | Neutral |
| Stochastic | 65.2 | Neutral |
PSHG's weekly RSI is 60 (neutral) and its Stochastic is 65 (neutral).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
PSHG PE vs Industrials Sector
| Metric | PSHG | Sector median | Relative |
|---|---|---|---|
| PE | 2.2x | 24x | 91% below |
| PE % | 99 | 58 | 41 pts above |
PSHG has the edge over VRT on valuation relative to its sector.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
PSHG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.75 | 15% above |
| 20 week MA | $1.74 | 16% above |
| 50 week MA | $1.89 | 6.9% above |
| 100 week MA | $1.82 | 11% above |
| 200 week MA | $1.80 | 12% above |
PSHG has the edge over VRT on trend strength, trading above more of its moving averages.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.
PSHG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $124.5 | $75.9 | -39% |
| 2021 | $75.9 | $67.7 | -11% |
| 2022 | $67.7 | $3.28 | -95% |
| 2023 | $3.28 | $2.27 | -31% |
| 2024 | $2.27 | $1.83 | -19% |
| 2025 | $1.83 | $2.31 | +26% |
| 2026 YTD | $2.31 | $2.02 | -13% |
PSHG has finished lower in five of the last six years. It's down 13% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over PSHG on returns for 2026, with the stronger performance.